Amgen Inc.
CH ˙ SWX ˙ NL0000888691
SecurityCH:AMGN / Amgen Inc.
InstitutionTwelve Points Wealth Management LLC
Latest Disclosed Ownership3,048 shares
Latest Disclosed Value $ 1,072,451
Twelve Points Wealth Management LLC reports 20.86% increase in ownership of AMGN / Amgen Inc.

On April 14, 2026 - Twelve Points Wealth Management LLC filed a 13F-HR form disclosing ownership of 3,048 shares of Amgen Inc. (CH:AMGN) valued at $1,072,451 USD as of March 31, 2026. The entity filed a previous 13F-HR on January 23, 2026 disclosing 2,522 shares of Amgen Inc.. This represents a change in shares of 20.86% during the quarter.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date
Effective
Date
Form Security Class ID Avg Price
Paid (Est)
Reported
Shares
ΔShares ΔShares
(%)
Reported
Value
(x1000)
ΔValue
(%)
Alloc
(%)
ΔAlloc ΔAlloc (%) Cost Basis
(x1000)
Unrealized
Gain/Loss
(x1000)
2026-04-14 2026-03-31 13F AMGEN COM 031162100 3,048 526 20.86 1,072 30.41 0.2359
2026-01-23 2025-12-31 13F AMGEN COM 031162100 2,522 -801 -24.10 822 -12.27 0.1851
2025-10-22 2025-09-30 13F AMGEN COM 031162100 3,323 -285 -7.90 938 -6.95 0.2336
2025-07-16 2025-06-30 13F AMGEN COM 031162100 3,608 393 12.22 1,007 0.60 0.2711
2025-04-30 2025-03-31 13F AMGEN COM 031162100 3,215 -31 -0.96 1,002 18.32 0.2718
2025-01-23 2024-12-31 13F AMGEN COM 031162100 3,246 1,378 73.77 846 40.77 0.2432
2024-10-16 2024-09-30 13F AMGEN COM 031162100 1,868 153 8.92 602 12.34 0.1894
2024-07-12 2024-06-30 13F AMGEN COM 031162100 1,715 118 7.39 536 17.84 0.1885
2024-04-15 2024-03-31 13F AMGEN COM 031162100 1,597 -31 -1.90 454 -2.99 0.1662
2024-01-12 2023-12-31 13F AMGEN COM 031162100 1,628 87 5.65 469 13.04 0.2223
2023-10-18 2023-09-30 13F AMGEN COM 031162100 1,541 150 10.78 414 34.42 0.2062
2023-07-13 2023-06-30 13F AMGEN COM 031162100 1,391 143 11.46 309 2.33 0.1643
2023-04-18 2023-03-31 13F AMGEN COM 031162100 1,248 131 11.73 302 2.73 0.1731
2023-01-17 2022-12-31 13F AMGEN COM 031162100 1,117 -8 -0.71 293 15.35 0.1997
2022-10-20 2022-09-30 13F AMGEN COM 031162100 1,125 19 1.72 254 -5.58 0.1971
2022-07-18 2022-06-30 13F AMGEN COM 031162100 1,106 100 9.94 269 10.70 0.2072
2022-05-11 2022-03-31 13F AMGEN COM 031162100 1,006 1,006 243 0.1815
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.